Leukemia: Chronic Myelomonocytic

+ -Text Size

Treating Leukemia - Chronic Myelomonocytic (CMML) TOPICS

How is chronic myelomonocytic leukemia treated?

This information represents the views of the doctors and nurses serving on the American Cancer Society’s Cancer Information Database Editorial Board. These views are based on their interpretation of studies published in medical journals, as well as their own professional experience.
The treatment information in this document is not official policy of the Society and is not intended as medical advice to replace the expertise and judgment of your cancer care team. It is intended to help you and your family make informed decisions, together with your doctor.
Your doctor may have reasons for suggesting a treatment plan different from these general treatment options. Don’t hesitate to ask him or her questions about your treatment options.

General treatment information about chronic myelomonocytic leukemia

Treatment of chronic myelomonocytic (MY-eh-loh-MAH-noh-SIH-tik) leukemia (CMML) is based on how severe the disease is, as well as the patient’s age and health. Patients with CMML are treated by specialists such as hematologists or oncologists.

Treatment for CMML may include:

See the “Additional resources ” section for a list of other, more detailed materials on the different types of cancer treatments and their side effects.


Last Medical Review: 01/19/2014
Last Revised: 03/21/2014